have evaluated the performance of the Menarini-Arkray HbA1c analyzer and have shown correlations of results on patient samples with the Bio-Rad Variant analyzer, an in-house HPLC method, a latex particle immunoassay, and an affinity chromatography method. The y ϭ x lines in Fig. 2, b and d , do not appear to be in the correct position, probably because the x and y axes are numbered differently.
Dr. John responds:
To the Editor: Drs. Nisbet and Boa are correct in their observation. The error occurred because the computer generated a 45-degree line without taking the axes into consideration. The addition of this line was at the reviewer's request, and was therefore done at a late stage in the production of the manuscript.
The statistical calculations and regression lines are correct.
The article's message is unchanged.
W. Garry John

Department of Clinical Biochemistry
The (4 -8) . This is because in theory S-cMg com can be calculated easily from the difference: ultrafilterable total magnesium (UF-cMg) Ϫ S-cMg 2ϩ . However, recent investigations in this area failed to resolve the original discrepancy. Altura and Altura (4) found a value of 14% for S-cMg com with the Nova 8 analyzer. However, because their ultrafiltration was done aerobically and without pH control, they obtained these values only after sparkling native samples (at pH 7.4) with CO 2 . If they had not sparkled the samples with CO 2 , they would have calculated a negative value for S-cMg com , namely Ϫ1% (5). Filos and Okorodudu (6), using the AVL 988-4 analyzer, and Kü lpmann and Gerlach (7), using the Kone Microlyte 6 analyzer, found a value of 5%, whereas Huijgen et al. (8) , using the Kone Microlyte 6 analyzer, reported a value of 8%. These differences may stem from two limitations in the calculation of S-cMg com from UF-cMg and S-cMg 2ϩ . First, the value for UFcMg depends on the ultrafiltration procedure applied (4, 5) . Second, the measurement of S-cMg 2ϩ by ISE has not been standardized, hence the true value of S-cMg 2ϩ is unknown. Indeed, different values for S-cMg 2ϩ are obtained with different ISE systems (9) . Moreover, in the absence of adequate quality-control materials, different instruments from the same manufacturer might give different values for S-cMg 2ϩ (10) . In addition, because of the combined effect of differences in ultrafiltration procedures and variable calibration of individual instruments, values reported for S-cMg com cannot be related to the calibration of certain ISE systems. Therefore, we conclude that calculating S-cMg com from UFcMg and S-cMg 2ϩ is not valid at this time.
Instead of calculating S-cMg com , we measured S-cMg com in the serum system by adding known complexing anions, such as citrate, phosphate, bicarbonate, and lactate, to serum samples. In this way, we avoided ultrafiltration and made S-cMg com determination independent of the calibration of the ISE system used. We added 20 L of a concentrated solution of sodium salts of bicarbonate, citrate, lactate, and monohydrogen phosphate as complexing agents to one aliquot of a serum sample to obtain twice the original concentration of the respective complexants. To the reference aliquot, we added 20 L of an equivalent NaCl solution. We then measured S-cMg 2ϩ in both aliquots with the AVL 988-4 instrument (AVL List GmbH). Using this procedure, we found a value of 10.4% for S-cMg com (Ϯ 1%, 95% confidence interval), which is between the 5.5% found by Speich et al. Note that S-cMg com , measured by ISE, needs to be corrected for the water displacement effect by the serum proteins when it is related to S-cMg. Furthermore, our approach assumes, for example, that the added phosphate (1.09 mmol/L) complexes the same amount of magnesium as the phosphate already present (mean, 1.09 mmol/L). This is justified because the functions calculated from the theoretical complexation constants are quasi-linear in the range we investigated (8) . In addition, complexation decreased proportionally when the concentrations of added complexants were only one-half of the concentrations of the original complexants.
On the other hand, when reliable values for S-cMg com and UF-cMg become available, we should be able to calculate S-cMg 2ϩ by subtracting S-cMg com and serum protein-bound magnesium (S-cMg pb ) from S-cMg (Note: S-cMg pb ϭ S-cMg Ϫ UF-cMg). If S-cMg 2ϩ correlates reasonably well with S-cMg, a practical standardization approach for S-cMg 2ϩ , based on S-cMg, should be possible. To investigate this, we measured the S-cMg and UF-cMg in 12 serum samples with an ion chromatography reference method (11); for S-cMg pb , we found a value of 31.5% (Ϯ 1.6%, 95% confidence interval), which is in good agreement with the 33.7% reported by Speich et al. (2) (Note: Like S-cMg com , UF-cMg must also be corrected). According to the above proposal, our data would yield a calculated value of 58.1% for S-cMg 2ϩ . We measured S-cMg 2ϩ with the AVL 988-4 and found an excellent correlation between S-cMg and pH-normalized S-cMg 2ϩ in a panel of 57 serum samples (r ϭ 0.9223; P Ͻ0.001; S-cMg range, 0.74 -0.92 mmol/L).
From these preliminary results, we concluded that standardization of S-cMg 2ϩ on the basis of S-cMg is a realistic option. We will undertake additional experiments to substantiate our observation that, for serum samples from apparently healthy donors, S-cMg 2ϩ accounts for ϳ58% of S-cMg (the fraction is usually assumed to be 65%).
